| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |